Holen Sie sich die Stockscreener-App
0.6695
13.26%
0.0784
Schlusskurs vom Vortag:
$0.5911
Offen:
$0.648
24-Stunden-Volumen:
55,014
Relative Volume:
0.23
Marktkapitalisierung:
$5.64M
Einnahmen:
$11.42M
Nettoeinkommen (Verlust:
$-2.89M
KGV:
-1.7572
EPS:
-0.381
Netto-Cashflow:
$-1.38M
1W Leistung:
+10.21%
1M Leistung:
-41.78%
6M Leistung:
-73.64%
1J Leistung:
-73.95%
1-Tages-Spanne:
$0.6109
$0.6649
1-Wochen-Bereich:
$0.5888
$0.67
52-Wochen-Spanne:
$0.5772
$3.0191
Nexgel Inc Stock (NXGL) Company Profile
Firmenname
Nexgel Inc
Sektor
Telefon
215 702-8550
Adresse
2150 CABOT BLVD WEST,, LANGHORNE
Compare NXGL vs ISRG, BDX, ALC, MDLN, RMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NXGL
Nexgel Inc
|
0.6649 | 5.01M | 11.42M | -2.89M | -1.38M | -0.381 |
ISRG
Intuitive Surgical Inc
|
452.02 | 160.56B | 10.06B | 2.88B | 2.49B | 7.876 |
BDX
Becton Dickinson Co
|
155.08 | 43.95B | 21.92B | 1.76B | 2.63B | 6.1223 |
ALC
Alcon Inc
|
74.53 | 36.34B | 10.40B | 980.00M | 1.61B | 1.9749 |
MDLN
Medline Inc
|
43.87 | 35.94B | 28.43B | 1.16B | 1.26B | 1.4457 |
RMD
Resmed Inc
|
224.10 | 32.65B | 5.40B | 1.49B | 1.78B | 10.12 |
Nexgel Inc Aktie (NXGL) Neueste Nachrichten
Exclusive: NexGel to acquire regenerative biomaterial portfolio from Celularity, expects to triple revenue - MSN
Fed Watch: Is NEXGEL Inc Equity Warrant still a buy after recent gains - baoquankhu1.vn
Shootin' the Bull about "has to" - barchart.com
NXGL SEC FilingsNexgel Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Published on: 2026-04-01 05:28:13 - baoquankhu1.vn
NexGel (NXGL) Releases Q4 2025 Earnings: Revenue Down, Losses Narrow, Cash Tight - Quiver Quantitative
NXGL: Revenue up 31.5% to $11.4M, but ongoing losses and liquidity risks persist - TradingView
Nexgel 2025 10-K: Revenues $11.4M, EPS (0.38) - TradingView
NexGel (NASDAQ: NXGL) grows 2025 revenue 31% but warns on going concern - Stock Titan
NEXGEL, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
NXGL PE Ratio & Valuation, Is NXGL Overvalued - Intellectia AI
NEXGEL Reschedules 2025 Financial Results Conference Call to April 8th at 4:30 P.M. ET to Provide Shareholders with an Update on Its Previously Announced Transaction with Celularity - MarketScreener
NEXGEL delays earnings call a week to add detail on Celularity deal - Stock Titan
Trend Report: Should you avoid NEXGEL Inc stock right nowWeekly Profit Analysis & Reliable Momentum Entry Alerts - baoquankhu1.vn
How does NEXGEL Inc Equity Warrant score in quality rankingsWeekly Loss Report & Consistent Growth Stock Picks - baoquankhu1.vn
The Metals Company: Unlocking a Klondike-Quality Mineral Rush - Barchart.com
NEXGEL to pay $15 million for Celularity regenerative biomaterial portfolio - MSN
Insider Trends: Is NEXGEL Inc stock technically oversoldWeekly Gains Report & Weekly Market Pulse Updates - baoquankhu1.vn
Johanna Gonzalez Announces TRUE 4G Method - Barchart.com
Published on: 2026-03-28 04:45:25 - baoquankhu1.vn
Nexgel Inc expected to post a loss of 9 cents a shareEarnings Preview - TradingView
NexGel Inc Stock: Innovative Medical Gels Positioned for Growth in Healthcare and Beauty Markets - AD HOC NEWS
3 Stocks Under $50 That Concern Us - Barchart.com
NEXGEL secures $1.8 million financing for potential acquisition - MSN
NEXGEL signs agreement to acquire regenerative biomaterial portfolio - MSN
NEXGEL to Report Fourth Quarter and Full Year 2025 Financial Results on March 31st - marketscreener.com
NEXGEL sets March 31 earnings release, 4:30 p.m. ET call - Stock Titan
Oxford Industries Earnings: What To Look For From OXM - Barchart
NEXGEL (NXGLW) Expected to Announce Earnings on Monday - Defense World
NEXGEL to Pay $15 Million for Celularity Regenerative Biomaterial Portfolio - MyChesCo
Portfolio Recap: Can NEXGEL Inc stock double in the next year2026 Key Lessons & Real-Time Stock Price Movement Reports - baoquankhu1.vn
Is Cooper Companies Stock Underperforming the Dow? - Barchart.com
Market Pulse: Whats the beta of NEXGEL Inc stock2026 Levels & Safe Swing Trade Setups - baoquankhu1.vn
Market Outlook: Can NEXGEL Inc stock double in the next year2026 Momentum Check & Advanced Technical Analysis Signals - baoquankhu1.vn
NEXGEL Signs Agreement to Acquire Regenerative Biomaterial Portfolio - MyChesCo
NexGel (NXGL) Expected to Announce Earnings on Monday - Defense World
NexGel to license, acquire regenerative biomaterial products - Investing.com Nigeria
UmzugsPreisChecker Announces 50,000 Moves Milestone - Barchart.com
NexGel, IncCommon Stock (NQ: NXGL - The Chronicle-Journal
NEXGEL discloses $15M upfront payment for Celularity portfolio By Investing.com - Investing.com Canada
NXGL Stock: NEXGEL Signs Deal to Triple Revenue and Turn Profitable With Acquisition of Six Commercial-Stage Regenerative Biomaterial Products - Barchart
NEXGEL discloses $15M upfront payment for Celularity portfolio - Investing.com
Celularity Reiterates Strategic Commercialization Partnership with NEXGEL Focused on Building Biomaterials Franchise with Established Commercial Products and New 510(k) Pathway Product Opportunities - The Manila Times
NEXGEL Announces Consideration Terms of Agreement to License and Acquire Portfolio of Commercial-Stage Regenerative Biomaterial Products - marketscreener.com
NEXGEL Announces Consideration Terms of Agreement to - GlobeNewswire
Inside Celularity’s bet on NEXGEL to shake up wound care biomaterials - Stock Titan
Asymmetry Point LP holds 610,000 shares of NexGel (NXGL) reporting 7.49% stake - Stock Titan
Biotechnology company Celularity Inc. (NASDAQ: CELU) recently reaffirmed its strategic commercialization partnership with NEXGEL, INC. (NASDAQ: NXGL). - Bitget
NexGel to license, acquire regenerative biomaterial products By Investing.com - Investing.com Canada
OSI Systems (OSIS): 3 Reasons We Love This Stock - Barchart.com
NexGel Acquires Celularity Regenerative Biomaterials in Transformative Deal - TipRanks
Finanzdaten der Nexgel Inc-Aktie (NXGL)
Umsatz
Nettogewinn
Free Cashflow
ENV
Nexgel Inc-Aktie (NXGL) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Levy Adam R. | Chief Executive Officer |
Dec 24 '25 |
Sale |
1.57 |
4,000 |
6,286 |
357,692 |
0.73%
0.18%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):